IDEXX Laboratories (IDXX) Debt/Assets Ratio: History & Chart

IDEXX Laboratories, Inc.(IDXX)

Medical - Diagnostics & Research · Westbrook, ME

$521.74-13.64 (-2.55%)

Delayed quote: Sep 8, 2026, 3:20 PM EDT

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Westbrook, ME

11,000 employees

www.idexx.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Michael Erickson

View full financials

IDXX Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

31.84%

DEBT TO ASSETS RATIO AVG TTM

33.33%

DEBT TO ASSETS RATIO AVG 3Y

32.29%

DEBT TO ASSETS RATIO AVG 5Y

39.12%

DEBT TO ASSETS RATIO AVG 10Y

52.09%

DEBT TO ASSETS RATIO AVG 15Y

48.98%

DEBT TO ASSETS RATIO AVG 20Y

40.53%

CURRENT VS TTM AVG

-4.47%

CURRENT VS 3Y AVG

-1.40%

CURRENT VS 5Y AVG

-18.61%

CURRENT VS 10Y AVG

-38.87%

CURRENT VS 15Y AVG

-35.00%

CURRENT VS 20Y AVG

-21.43%

SECTOR MEDIAN · HEALTHCARE

0.28%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

+11271.86%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
IDEXX Laboratories, Inc. (IDXX)	$41.16B	31.84%	33.33%	32.29%	39.12%
Agilent Technologies, Inc. (A)vs ›	$41.66B	0.28%	N/A	N/A	N/A
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$42.98B	0.42%	N/A	N/A	N/A
IQVIA Holdings Inc. (IQV)vs ›	$43.07B	0.54%	N/A	N/A	N/A
Alnylam Pharmaceuticals, Inc. (ALNY)vs ›	$35.01B	0.23%	N/A	N/A	N/A
Alcon Inc. (ALC)vs ›	$33.80B	0.17%	N/A	N/A	N/A
Humana Inc. (HUM)vs ›	$48.81B	0.25%	N/A	N/A	N/A
Becton, Dickinson and Company (BDX)vs ›	$49.72B	0.33%	N/A	N/A	N/A
ResMed Inc. (RMD)vs ›	$32.30B	0.09%	N/A	N/A	N/A
Edwards Lifesciences Corporation (EW)vs ›	$50.19B	0.05%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

IDEXX Laboratories, Inc. (IDXX)

$41.16B

31.84%

33.33%

32.29%

39.12%

Agilent Technologies, Inc. (A)vs ›

$41.66B

0.28%

N/A

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$42.98B

0.42%

N/A

IQVIA Holdings Inc. (IQV)vs ›

$43.07B

0.54%

N/A

Alnylam Pharmaceuticals, Inc. (ALNY)vs ›

$35.01B

0.23%

N/A

Alcon Inc. (ALC)vs ›

$33.80B

0.17%

N/A

Humana Inc. (HUM)vs ›

$48.81B

0.25%

N/A

Becton, Dickinson and Company (BDX)vs ›

$49.72B

0.33%

N/A

ResMed Inc. (RMD)vs ›

$32.30B

0.09%

N/A

Edwards Lifesciences Corporation (EW)vs ›

$50.19B

0.05%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for IDEXX Laboratories, Inc. (IDXX)?

The debt to assets ratio for IDXX stock is 31.84%.

Is IDEXX Laboratories, Inc.'s debt to assets ratio high or low?

The debt to assets ratio of 31.84% is 19% below its 5-year average of 39.12%, near the low end of its 5-year range (29.79%–57.41%).

What is the TTM average debt to assets ratio for IDEXX Laboratories, Inc. (IDXX)?

The TTM average debt to assets ratio for IDXX stock is 33.33%.

What is the 3Y average debt to assets ratio for IDEXX Laboratories, Inc. (IDXX)?

The 3Y average debt to assets ratio for IDXX stock is 32.29%.

What is the 5Y average debt to assets ratio for IDEXX Laboratories, Inc. (IDXX)?

The 5Y average debt to assets ratio for IDXX stock is 39.12%.

What is the 10Y average debt to assets ratio for IDEXX Laboratories, Inc. (IDXX)?

The 10Y average debt to assets ratio for IDXX stock is 52.09%.

What is the 15Y average debt to assets ratio for IDEXX Laboratories, Inc. (IDXX)?

The 15Y average debt to assets ratio for IDXX stock is 48.98%.

What is the 20Y average debt to assets ratio for IDEXX Laboratories, Inc. (IDXX)?

The 20Y average debt to assets ratio for IDXX stock is 40.53%.

DATE	DEBT TO ASSETS RATIO
2026-06-30	31.84%
2026-03-31	32.65%
2025-12-31	32.15%
2025-09-30	32.86%
2025-06-30	37.15%
2025-03-31	32.96%
2024-12-31	29.97%
2024-09-30	29.79%
2024-06-30	31.27%
2024-03-31	31.88%
2023-12-31	32.74%
2023-09-30	36.94%
2023-06-30	40.16%
2023-03-31	47.01%
2022-12-31	53.52%
2022-09-30	57.05%
2022-06-30	57.41%
2022-03-31	49.51%
2021-12-31	42.30%
2021-09-30	40.37%
2021-06-30	41.98%
2021-03-31	42.96%
2020-12-31	43.72%
2020-09-30	48.38%
2020-06-30	56.42%
2020-03-31	67.07%
2019-12-31	58.41%
2019-09-30	57.51%
2019-06-30	64.13%
2019-03-31	67.18%
2018-12-31	65.07%
2018-09-30	65.84%
2018-06-30	68.40%
2018-03-31	69.17%
2017-12-31	73.60%
2017-09-30	77.30%
2017-06-30	79.71%
2017-03-31	80.52%
2016-12-31	78.66%
2016-09-30	72.46%
2016-06-30	77.62%
2016-03-31	82.64%
2015-12-31	79.33%
2015-09-30	77.31%
2015-06-30	74.25%
2015-03-31	73.34%
2014-12-31	64.95%
2014-09-30	56.17%
2014-06-30	41.61%
2014-03-31	36.93%
2013-12-31	34.81%
2013-09-30	33.37%
2013-06-30	31.74%
2013-03-31	23.16%
2012-12-31	19.44%
2012-09-30	21.47%
2012-06-30	23.14%
2012-03-31	24.24%
2011-12-31	23.91%
2011-09-30	16.26%
2011-06-30	14.35%
2011-03-31	14.37%
2010-12-31	14.86%
2010-09-30	15.12%
2010-06-30	16.62%
2010-03-31	19.69%
2009-12-31	15.32%
2009-09-30	18.15%
2009-06-30	20.07%
2009-03-31	22.22%
2008-12-31	20.44%
2008-09-30	21.81%
2008-06-30	21.45%
2008-03-31	19.84%
2007-12-31	11.21%
2007-09-30	12.44%
2007-06-30	14.01%
2007-03-31	12.71%
2006-12-31	1.27%
2006-09-30	1.39%
2006-06-30	1.49%
2006-03-31	0.00%
2005-12-31	0.11%
2005-09-30	0.11%
2005-06-30	0.11%
2005-03-31	0.11%
2004-12-31	0.35%
2004-09-30	0.23%
2004-06-30	0.23%
2004-03-31	0.27%
2003-12-31	0.25%
2003-09-30	0.10%
2003-06-30	0.10%
2003-03-31	0.23%
2002-12-31	0.24%
2002-09-30	0.23%

DATE

DEBT TO ASSETS RATIO

2026-06-30

31.84%

2026-03-31

32.65%

2025-12-31

32.15%

2025-09-30

32.86%

2025-06-30

37.15%

2025-03-31

32.96%

2024-12-31

29.97%

2024-09-30

29.79%

2024-06-30

31.27%

2024-03-31

31.88%

2023-12-31

32.74%

2023-09-30

36.94%

2023-06-30

40.16%

2023-03-31

47.01%

2022-12-31

53.52%

2022-09-30

57.05%

2022-06-30

57.41%

2022-03-31

49.51%

2021-12-31

42.30%

2021-09-30

40.37%

2021-06-30

41.98%

2021-03-31

42.96%

2020-12-31

43.72%

2020-09-30

48.38%

2020-06-30

56.42%

2020-03-31

67.07%

2019-12-31

58.41%

2019-09-30

57.51%

2019-06-30

64.13%

2019-03-31

67.18%

2018-12-31

65.07%

2018-09-30

65.84%

2018-06-30

68.40%

2018-03-31

69.17%

2017-12-31

73.60%

2017-09-30

77.30%

2017-06-30

79.71%

2017-03-31

80.52%

2016-12-31

78.66%

2016-09-30

72.46%

2016-06-30

77.62%

2016-03-31

82.64%

2015-12-31

79.33%

2015-09-30

77.31%

2015-06-30

74.25%

2015-03-31

73.34%

2014-12-31

64.95%

2014-09-30

56.17%

2014-06-30

41.61%

2014-03-31

36.93%

2013-12-31

34.81%

2013-09-30

33.37%

2013-06-30

31.74%

2013-03-31

23.16%

2012-12-31

19.44%

2012-09-30

21.47%

2012-06-30

23.14%

2012-03-31

24.24%

2011-12-31

23.91%

2011-09-30

16.26%

2011-06-30

14.35%

2011-03-31

14.37%

2010-12-31

14.86%

2010-09-30

15.12%

2010-06-30

16.62%

2010-03-31

19.69%

2009-12-31

15.32%

2009-09-30

18.15%

2009-06-30

20.07%

2009-03-31

22.22%

2008-12-31

20.44%

2008-09-30

21.81%

2008-06-30

21.45%

2008-03-31

19.84%

2007-12-31

11.21%

2007-09-30

12.44%

2007-06-30

14.01%

2007-03-31

12.71%

2006-12-31

1.27%

2006-09-30

1.39%

2006-06-30

1.49%

2006-03-31

0.00%

2005-12-31

0.11%

2005-09-30

0.11%

2005-06-30

0.11%

2005-03-31

0.11%

2004-12-31

0.35%

2004-09-30

0.23%

2004-06-30

0.23%

2004-03-31

0.27%

2003-12-31

0.25%

2003-09-30

0.10%

2003-06-30

0.10%

2003-03-31

0.23%

2002-12-31

0.24%

2002-09-30

0.23%

Debt to Assets Ratio: 31.84%

IDXX Debt to Assets Ratio

IDXX Average Debt to Assets Ratio Chart

IDXX Current vs Average Debt to Assets Ratio Chart

IDXX Debt to Assets Ratio Metrics

IDXX Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

IDXX Debt to Assets Ratio History

Related Metrics